{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:09:27Z","timestamp":1769011767445,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jdcr.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T12:02:59Z","timestamp":1600171379000},"page":"1234-1235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ustekinumab-induced fixed drug eruption"],"prefix":"10.1016","volume":"6","author":[{"given":"Dhafer M.","family":"Hafez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Njood","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najla A.","family":"Al-Dawsari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2020.09.005_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.1985.tb15266.x","article-title":"Fixed eruptions: causative drugs and challenge tests","volume":"112","author":"Kauppinen","year":"1985","journal-title":"Br J Dermatol"},{"issue":"9625","key":"10.1016\/j.jdcr.2020.09.005_bib2","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jdcr.2020.09.005_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archdermatol.2011.161","article-title":"Reversible posterior leukoencephalopathy syndrome in a patient treated with ustekinumab: case report and review of the literature","volume":"147","author":"Gratton","year":"2011","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.jdcr.2020.09.005_bib4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archdermatol.2011.213","article-title":"Lymphomatoid drug reaction to ustekinumab","volume":"147","author":"Jung","year":"2011","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2020.09.005_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2340\/00015555-1441","article-title":"Recurrent erythema annulare centrifugum during ustekinumab treatment in a psoriatic patient","volume":"93","author":"Chou","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.jdcr.2020.09.005_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jdcr.2015.07.014","article-title":"Bullous pemphigoid during ustekinumab therapy","volume":"1","author":"Le Guern","year":"2015","journal-title":"JAAD Case Rep"},{"issue":"8","key":"10.1016\/j.jdcr.2020.09.005_bib7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archdermatol.2012.586","article-title":"Eczematous drug eruption after ustekinumab treatment","volume":"148","author":"Pernet","year":"2012","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2020.09.005_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jdcr.2020.03.002","article-title":"Erythema multiforme after initiation of anti interleukin-12\/23 (ustekinumab) treatment for plaque psoriasis","volume":"6","author":"Burlando","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"7","key":"10.1016\/j.jdcr.2020.09.005_bib9","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.jaip.2019.06.028","article-title":"Fixed drug eruption to biologics and role of lesional patch testing","volume":"7","author":"Li","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.jdcr.2020.09.005_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3315\/jdcr.2008.1018","article-title":"Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis","volume":"2","author":"Wollina","year":"2008","journal-title":"J Dermatol Case Rep"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262030669X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262030669X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:22:45Z","timestamp":1762474965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262030669X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S235251262030669X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.09.005","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ustekinumab-induced fixed drug eruption","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}